“Increasing Adoption of Antibiotic Therapy in Bejel Treatment Market”
A key trend driving growth in the bejel treatment market is the increasing adoption of antibiotic therapies, particularly penicillin-based drugs. Bejel, caused by Treponema pallidum, has been traditionally treated with penicillin, and its effectiveness continues to make it a first-line treatment. In recent years, there has been a growing recognition of the importance of early intervention with antibiotics to prevent complications. For instance, in regions such as Sub-Saharan Africa and parts of the Middle East, the availability of affordable penicillin-based treatments has led to improved outcomes. In addition, public health campaigns focused on syphilis and related diseases have contributed to the rise in antibiotic usage, boosting the market.
